Breaking: Pfizer development chief Rod MacKenzie is retiring after a lengthy career capped by historic success
Pfizer’s clinical development chief and EVP Rod MacKenzie is retiring from his post at the pharma giant, right on the heels of a historic success.
MacKenzie was one of the leaders in Pfizer’s bold push to take an mRNA vaccine from their partners at BioNTech, and was there with CEO Albert Bourla and R&D chief Mikael Dolsten when they took the wraps off the promising pivotal data that set the stage for a speedy FDA approval following an emergency use authorization.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,300+ biopharma pros reading Endpoints daily — and it's free.